MVA E2 therapeutic vaccine for marked reduction in likelihood of recurrence of respiratory papillomatosis. [electronic resource]

By: Contributor(s): Producer: 20201007Description: 657-665 p. digitalISSN:
  • 1097-0347
Subject(s): Online resources: In: Head & neck vol. 41
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't

There are no comments on this title.

to post a comment.